» Authors » Takehito Imado

Takehito Imado

Explore the profile of Takehito Imado including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 181
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshihara S, Yoshihara K, Shimizu Y, Imado T, Takatsuka H, Kawamoto H, et al.
Hematology . 2021 May; 26(1):388-392. PMID: 34000225
Objectives: Achieving a deep response with induction therapy has a major impact on outcomes following autologous stem cell transplantation. Although longer and intensified induction therapy may provide better disease control,...
2.
Yoshihara K, Yoshihara S, Matsuda I, Imado T, Matsuo S, Okada M, et al.
Ann Hematol . 2020 Mar; 99(6):1405-1407. PMID: 32125468
No abstract available.
3.
Imado T, Iwasaki T, Kitano S, Satake A, Kuroiwa T, Tsunemi S, et al.
Transplantation . 2010 Oct; 90(10):1063-70. PMID: 20975627
Background: Mutations in Toll-like receptor (TLR)-4 have been associated with the hyporesponsiveness of macrophages to lipopolysaccharide, possibly reducing the risk of acute graft-versus-host disease (GVHD). However, TLR-4 mutations may also...
4.
Tsunemi S, Iwasaki T, Kitano S, Imado T, Miyazawa K, Sano H
Clin Immunol . 2010 Apr; 136(2):197-204. PMID: 20421177
We investigated the effects and mechanisms by which FTY720 (FTY) inhibits arthritis development in the SKG mouse rheumatoid arthritis (RA) model. FTY (1mg/kg/day) administration suppressed the progression of laminarin-induced arthritis...
5.
Satake A, Inoue T, Kubo S, Taniguchi Y, Imado T, Fujioka T, et al.
Int J Hematol . 2010 Mar; 91(3):485-97. PMID: 20300982
Allogeneic hematopoietic stem cell transplantation (HSCT) is associated with both graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) effects. In clinical studies of HLA-mismatched HSCT, strong GVL effects have been reported. In...
6.
Yoshida Y, Hirano T, Son G, Iimuro Y, Imado T, Iwasaki T, et al.
Am J Physiol Gastrointest Liver Physiol . 2007 Sep; 293(6):G1114-23. PMID: 17761834
Allogeneic bone-marrow transplantation (BMT) can induce a powerful graft-vs.-tumor (GVT) effect not only on hematological malignancies but also on solid tumors. However, graft-vs.-host disease (GVHD) is a major complication of...
7.
Iwasaki T, Imado T, Kitano S, Sano H
Arthritis Res Ther . 2006 Oct; 8(6):R161. PMID: 17049072
The tight-skin (TSK/+) mouse, a genetic model of systemic sclerosis (SSc), develops cutaneous fibrosis and defects in pulmonary architecture. Because hepatocyte growth factor (HGF) is an important mitogen and morphogen...
8.
Kuroiwa T, Iwasaki T, Imado T, Sekiguchi M, Fujimoto J, Sano H
Arthritis Res Ther . 2006 Jul; 8(4):R123. PMID: 16859527
Chronic graft-versus-host disease (GVHD) induced in (C57BL/6 x DBA/2) F1 (BDF1) mice by the injection of DBA/2 mouse spleen cells represents histopathological changes associated with systemic lupus erythematosus (SLE), primary...
9.
Tsunemi S, Iwasaki T, Imado T, Higasa S, Kakishita E, Shirasaka T, et al.
AIDS . 2005 May; 19(9):879-86. PMID: 15905668
Objective: To determine whether the frequencies of CD4+CD25+ regulatory T cells (T Reg) were related to immune status in HIV-infected patients. Methods: Peripheral blood CD4 T-cell populations were examined for...
10.
Imado T, Iwasaki T, Kataoka Y, Kuroiwa T, Hara H, Fujimoto J, et al.
Blood . 2004 Apr; 104(5):1542-9. PMID: 15100150
Graft-versus-host disease (GVHD) is a major complication of allogeneic bone marrow transplantation (BMT). When GVHD is controlled by T-cell-depleted grafts or immunosuppressants, BM transplant recipients often suffer from an increased...